Revolution Medicines financial statements

Name: Quantus Signal — KR/US technical signal dataset
License: https://www.quantus.kr/signal/terms

레볼루션 메디신NASDAQ:RVMD · Nasdaq · Healthcare

$207.68+0.50%

2026-10-05 close

Revolution Medicines's published financial data is dated 2026-10-04. 2024 revenue was $0M. 2024 operating profit was −$690M.

Reported results

Quantus Signal · live data · not investment advice · Privacy Policy